BioRelix

BioRelix is a biopharmaceutical company dedicated to discovering and developing antibiotic candidates for the treatment of infectious diseases in the United States. It has developed a series of riboswitch-based therapeutics to address the lethal and devastating causes of bacterial infections. The company was founded in 2005 and is headquartered in New Haven, Connecticut.